Canopy Growth Corp (NYSE:CGC) has coverage initiated with a Outperform rating and $107.57 price target

Analyst Ratings For Canopy Growth Corp (NYSE:CGC)

Story continues below

Today, Evercore ISI initiated coverage on Canopy Growth Corp (NYSE:CGC) with a Outperform with a price target of $107.57.

There are 10 Buy Ratings, 4 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Canopy Growth Corp (NYSE:CGC) is Buy with a consensus target price of $66.4288 per share, a potential 57.00% upside.

Some recent analyst ratings include

  • 6/12/2019-Canopy Growth Corp (NYSE:CGC) has coverage initiated with a Outperform rating and $107.57 price target
  • 6/10/2019-Canopy Growth Corp (NYSE:CGC) has coverage initiated with a Neutral rating and $43.76 price target
  • 6/5/2019-Canopy Growth Corp (NYSE:CGC) has coverage initiated with a Buy ➝ Buy rating and $40.83 price target
  • 5/13/2019-Canopy Growth Corp (NYSE:CGC) has coverage initiated with a Buy rating
  • 4/25/2019-Canopy Growth Corp (NYSE:CGC) has coverage initiated with a Buy ➝ Buy rating
  • 4/22/2019-Canopy Growth Corp (NYSE:CGC) gets upgraded to Buy by GMP Securities with a price target of $72.00

    About Canopy Growth Corp (NYSE:CGC)
    Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. Read More…

    Recent Trading Activity for Canopy Growth Corp (NYSE:CGC)
    Shares of Canopy Growth Corp closed the previous trading session at 42.25 −0.67 1.56% with 41.57 shares trading hands.

    An ad to help with our costs